Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.72B |
| 2 |
Linde
LIN
|
+$1.13B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$633M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$580M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$572M |
Top Sells
| 1 |
Fortive
FTV
|
+$1.06B |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
+$899M |
| 3 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$390M |
| 4 |
Amazon
AMZN
|
+$363M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$307M |
Sector Composition
| 1 | Technology | 14.52% |
| 2 | Healthcare | 11.16% |
| 3 | Financials | 11.03% |
| 4 | Communication Services | 9.66% |
| 5 | Consumer Discretionary | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARA
2726
DELISTED
American Renal Associates Holdings, Inc
ARA
| $153K | ﹤0.01% |
13,337
-55,817
| -81% | -$640K |
|
2727
Alaunos Therapeutics
TCRT
$5.1M
| $152K | ﹤0.01% |
544
-409
| -43% | -$114K |
|
2728
Janus Henderson
JHG
$7.01B
| $151K | ﹤0.01% |
7,283
-52,391
| -88% | -$1.09M |
|
2729
LendingClub
LC
$1.91B
| $151K | ﹤0.01% |
11,506
-19,367
| -63% | -$254K |
|
2730
HCI Group
HCI
$2.34B
| $150K | ﹤0.01% |
2,940
-5,224
| -64% | -$267K |
|
2731
Houlihan Lokey
HLI
$14.4B
| $149K | ﹤0.01% |
4,052
-14,568
| -78% | -$536K |
|
|
ADMS
2732
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $148K | ﹤0.01% |
17,387
+8,118
| +88% | +$69.1K |
|
2733
Stoneridge
SRI
$228M
| $147K | ﹤0.01% |
5,957
-10,554
| -64% | -$260K |
|
|
FPRX
2734
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $147K | ﹤0.01% |
15,848
-22,506
| -59% | -$209K |
|
2735
Willdan Group
WLDN
$1.48B
| $146K | ﹤0.01% |
4,177
+1,115
| +36% | +$39K |
|
|
BELFB
2736
Bel Fuse Class B
BELFB
$1.79B
| $145K | ﹤0.01% |
7,864
-5,743
| -42% | -$106K |
|
2737
Cytokinetics
CYTK
$6.12B
| $145K | ﹤0.01% |
23,049
-32,952
| -59% | -$207K |
|
2738
Q32 Bio
QTTB
$23.5M
| $145K | ﹤0.01% |
361
+144
| +66% | +$57.8K |
|
|
RRD
2739
DELISTED
RR Donnelley & Sons Co.
RRD
| $145K | ﹤0.01% |
36,792
-54,171
| -60% | -$213K |
|
|
LFC
2740
DELISTED
China Life Insurance Company Ltd.
LFC
| $144K | ﹤0.01% |
13,700
-39,979
| -74% | -$420K |
|
|
ATTU
2741
DELISTED
Attunity Ltd
ATTU
| $144K | ﹤0.01% |
7,300
| – | – |
|
2742
Brink's
BCO
$4.83B
| $143K | ﹤0.01% |
2,208
-36,389
| -94% | -$2.36M |
|
2743
Option Care Health
OPCH
$4.62B
| $143K | ﹤0.01% |
10,045
-7,161
| -42% | -$102K |
|
2744
Veeco
VECO
$1.52B
| $143K | ﹤0.01% |
19,397
-39,829
| -67% | -$294K |
|
|
HAYN
2745
DELISTED
Haynes International, Inc.
HAYN
| $143K | ﹤0.01% |
5,414
-8,478
| -61% | -$224K |
|
2746
Civista Bancshares
CIVB
$402M
| $142K | ﹤0.01% |
8,126
+2,995
| +58% | +$52.3K |
|
2747
Matador Resources
MTDR
$5.93B
| $142K | ﹤0.01% |
9,115
-65,719
| -88% | -$1.02M |
|
|
VAPO
2748
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $142K | ﹤0.01% |
+890
| New | +$142K |
|
|
NVRO
2749
DELISTED
NEVRO CORP.
NVRO
| $141K | ﹤0.01% |
3,626
-46,004
| -93% | -$1.79M |
|
2750
SPDR Bloomberg Convertible Securities ETF
CWB
$4.5B
| $140K | ﹤0.01% |
2,998
-2,968
| -50% | -$139K |
|